消息

Analysts highlight a shift in growth trajectory, with the company’s annualised revenue growth expected to accelerate to 6.1 % by year‑end 2026, aligning closely with the industry’s 6.3 % forecast. This positions Knorr‑Bremse to match peer growth rates.

全文

Knorr‑Bremse AG (KBX) reported a quarterly miss: revenues fell 2.7 % and statutory EPS dipped 6.5 % below analyst expectations. Despite the shortfall, the consensus from 14 analysts now forecasts a 4.5 % revenue rise to €8.25 bn in 2026, with statutory EPS projected to climb 27 % to €4.34. The average price target remains €113, reflecting a stable...

全文

With its early entry into voice‑based intoxication detection, MindBio seeks a first‑mover advantage in an emerging field. The dual‑channel strategy—consumer and enterprise—positions the company to commercialize its technology at both individual and industrial scales.

全文

The global workplace drug‑testing market is estimated at $15.4 billion, driven by regulatory requirements across these sectors. MindBio’s technology targets this market, providing faster and less invasive alternatives that could transform regulatory enforcement, workplace safety, and public health outcomes.

全文

MindBio has already launched a consumer application and is progressing an enterprise platform that includes Edge‑AI kiosks with bespoke hardware and software. These kiosks are aimed at high‑risk industries such as mining, aviation, construction, and transportation, where regulatory compliance and workforce safety demand rapid, scalable testing.

全文

The company’s solution is non‑invasive, contrasting with traditional breathalyzers and blood tests that are delayed or limited to single substances. By mapping speech patterns to internal physiological states, MindBio can assess multisubstance intoxication, offering a broader view of impairment that can enhance decision‑making in critical situation...

全文

MindBio Therapeutics Corp. (CSE: MBIO, OTCQB: MBQIF) is developing an AI‑driven voice‑analysis system that predicts drug and alcohol intoxication from short speech samples. The predictive models are trained on over 50 million data points, delivering high accuracy for real‑time impairment detection across multiple substances.

全文

On May 19 2026, Insight will present at J.P. Morgan’s 2026 Global Technology, Media and Communications Conference. CEO Jack Azagury and CFO James Morgado will appear live, with the webcast available at investor.insight.com. The company’s global presence includes over 6,000 partners and experts worldwide, positioning it as a leading solutions inte...

全文

Management attributes the margin expansion to a shift toward higher‑margin cloud and services, with net income of $30.01 million in Q1 2026. Insight plans to pause acquisitions in 2026 to focus on internal improvements, while FMR LLC’s 8.9 % passive institutional stake provides liquidity and signals confidence. Forecasts for 2028 project $9.6 bil...

全文

Insight Enterprises (NSIT) reported first‑quarter 2026 revenue of $2.13 billion, up 1.2 % YoY, matching the Zacks Consensus Estimate of $2.13 billion and falling 0.31 % short of analysts’ expectations. Net sales from services rose 16.6 % YoY to $461.44 million, surpassing estimates, while net sales from products fell 2.4 % YoY to $1.67 billion, be...

全文